With data from randomized controlled trials and RWE, Path conducts high-level analytics in cost-effectiveness, cost-utility, cost-benefit, and cost-minimization analyses. Such analytics are complementarily conducted with budget impact analysis and return on investment analysis. Path also provides localization for already constructed global value models. All of these can help your organization meet the requirements of HTA bodies, pricing, and reimbursement of your target audience.